You have 9 free searches left this month | for more free features.

Beijing (1)

Advanced Malignancies (1)

Active, not recruiting (1)

phase 1 (1)

Innovent Biologics (Suzhou) Co. Ltd. (1)

ibi939 (1)

ibi939+ sintilimab (1)

drug (1)

Industry (1)

Interventional (1)

ibi939

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Active, not recruiting

Oct 4, 2022